ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Why do gene therapy treatments cost so much? – Genetic Literacy Project

Continue reading

2017-09-15 Michael Zand NEWS

Cancer control: immunotherapy offers solution to a cure – Axios

Why do gene therapy treatments cost so much?
Genetic Literacy Project
The industry’s warnings that without high reimbursements, the field of gene therapy will wither is “the classic story of the boy who cried wolf,” said [Dr. Peter B. Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering …

Continue reading

2017-09-15 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 2.8% Above Its 50 Day Average – Modern Readers

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 2.8% Above Its 50 Day AverageModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella … Continue reading

2017-09-15 Michael Zand NEWS

Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A – Labiotech.eu (blog)


Axios

Cancer control: immunotherapy offers solution to a cure
Axios
“The greatest excitement is reserved for immunotherapy, a new approach that has emerged in the past few years. The human immune system is equipped with a set of brakes that cancer cells are able to activate; the first immunotherapy treatment in effect …

Continue reading

2017-09-15 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 2.8% Above Its 50 Day Average – Modern Readers

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 2.8% Above Its 50 Day AverageModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella … Continue reading

2017-09-15 Michael Zand NEWS

$11.6 Million NIH Grant Supports Temple Researchers’ Exploration of New Cell-Free Stem Cell-Based Possibilities in … – Newswise (press release)


Labiotech.eu (blog)

Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A
Labiotech.eu (blog)
With the microbiome already gaining traction in the therapeutics field, Bayer has decided to take it to agriculture. In partnership with US synthetic biology upstart Ginkgo Bioworks, the German giant is creating a new company to engineer plant …

and more »

Continue reading

2017-09-15 Michael Zand NEWS

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula – Medical Xpress

$11.6 Million NIH Grant Supports Temple Researchers’ Exploration of New Cell-Free Stem Cell-Based Possibilities in …
Newswise (press release)
Newswise — The incidence of heart disease is on the rise, and new therapeutic strategies are needed. Approaches based on stem cells, which can potentially preserve or even regenerate heart muscle cells damaged by ischemia – a hallmark of heart …
Mesenchymal Stem Cells Market to Observe Strong Development by 2020satPRnews (press release)

all 2 news articles »

Continue reading

2017-09-15 Michael Zand NEWS

Editas Medicine (EDIT) vs. Oramed Pharmaceuticals (ORMP) Head to Head Contrast – Dispatch Tribunal

MoneyMakingArticlesEditas Medicine (EDIT) vs. Oramed Pharmaceuticals (ORMP) Head to Head ContrastDispatch TribunalCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR … Continue reading

2017-09-15 Michael Zand NEWS
  • 1
  • …
  • 1,197
  • 1,198
  • 1,199
  • 1,200
  • 1,201
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula
Medical Xpress
A growing body of clinical evidence shows that transplantation of a patient’s own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn’s disease-related fistula can be a safe and effective addition to surgery. A comprehensive …